Literature DB >> 21084466

Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy infection following passage in sheep.

Chris Plinston1, Patricia Hart, Angela Chong, Nora Hunter, James Foster, Pedro Piccardo, Jean C Manson, Rona M Barron.   

Abstract

The risk of the transmission of ruminant transmissible spongiform encephalopathy (TSE) to humans was thought to be low due to the lack of association between sheep scrapie and the incidence of human TSE. However, a single TSE agent strain has been shown to cause both bovine spongiform encephalopathy (BSE) and human vCJD, indicating that some ruminant TSEs are transmissible to humans. While the transmission of cattle BSE to humans in transgenic mouse models has been inefficient, indicating the presence of a significant transmission barrier between cattle and humans, BSE has been transmitted to a number of other species. Here, we aimed to further investigate the human transmission barrier following the passage of BSE in a sheep. Following inoculation with cattle BSE, gene-targeted transgenic mice expressing human PrP showed no clinical or pathological signs of TSE disease. However, following inoculation with an isolate of BSE that had been passaged through a sheep, TSE-associated vacuolation and proteinase K-resistant PrP deposition were observed in mice homozygous for the codon 129-methionine PRNP gene. This observation may be due to higher titers of the BSE agent in sheep or an increased susceptibility of humans to BSE prions following passage through a sheep. However, these data confirm that, contrary to previous predictions, it is possible that a sheep prion is transmissible to humans and that BSE from other species is a public health risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084466      PMCID: PMC3020518          DOI: 10.1128/JVI.01578-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  BSE agent signatures in a goat.

Authors:  Marc Eloit; Karim Adjou; Muriel Coulpier; Jean Jacques Fontaine; Rodolphe Hamel; Thomas Lilin; Sebastien Messiaen; Olivier Andreoletti; Thierry Baron; Anna Bencsik; Anne Gaelle Biacabe; Vincent Beringue; Hubert Laude; Annick Le Dur; Jean Luc Vilotte; Emmanuel Comoy; Jean Philippe Deslys; Jacques Grassi; Stephanie Simon; Frederic Lantier; Pierre Sarradin
Journal:  Vet Rec       Date:  2005-04-16       Impact factor: 2.695

2.  The same prion strain causes vCJD and BSE.

Authors:  A F Hill; M Desbruslais; S Joiner; K C Sidle; I Gowland; J Collinge; L J Doey; P Lantos
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

3.  Distribution of experimentally induced scrapie lesions in the brain.

Authors:  H Fraser; A G Dickinson
Journal:  Nature       Date:  1967-12-30       Impact factor: 49.962

4.  Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.

Authors:  Matthew T Bishop; Robert G Will; Jean C Manson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

5.  Tissue distribution of bovine spongiform encephalopathy infectivity in Romney sheep up to the onset of clinical disease after oral challenge.

Authors:  S J Bellworthy; S A C Hawkins; R B Green; I Blamire; G Dexter; I Dexter; R Lockey; M Jeffrey; S Ryder; C Berthelin-Baker; M M Simmons
Journal:  Vet Rec       Date:  2005-02-12       Impact factor: 2.695

6.  Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.

Authors:  Juan Carlos Espinosa; Olivier Andréoletti; Joaquín Castilla; María Eugenia Herva; Mónica Morales; Elia Alamillo; Fayna Díaz San-Segundo; Caroline Lacroux; Séverine Lugan; Francisco Javier Salguero; Jan Langeveld; Juan María Torres
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 7.  Bovine spongiform encephalopathy (BSE)--infectious, contagious, zoonotic or production disease?

Authors:  Marcus G Doherr
Journal:  Acta Vet Scand Suppl       Date:  2003

8.  Unaltered susceptibility to BSE in transgenic mice expressing human prion protein.

Authors:  J Collinge; M S Palmer; K C Sidle; A F Hill; I Gowland; J Meads; E Asante; R Bradley; L J Doey; P L Lantos
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

9.  Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain.

Authors:  Qingzhong Kong; Mengjie Zheng; Cristina Casalone; Liuting Qing; Shenghai Huang; Bikram Chakraborty; Ping Wang; Fusong Chen; Ignazio Cali; Cristiano Corona; Francesca Martucci; Barbara Iulini; Pierluigi Acutis; Lan Wang; Jingjing Liang; Meiling Wang; Xinyi Li; Salvatore Monaco; Gianluigi Zanusso; Wen-Quan Zou; Maria Caramelli; Pierluigi Gambetti
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

10.  Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep.

Authors:  Jan P M Langeveld; Jorg G Jacobs; Jo H F Erkens; Alex Bossers; Fred G van Zijderveld; Lucien J M van Keulen
Journal:  BMC Vet Res       Date:  2006-06-09       Impact factor: 2.741

View more
  27 in total

1.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

2.  Susceptibility of domestic cats to chronic wasting disease.

Authors:  Candace K Mathiason; Amy V Nalls; Davis M Seelig; Susan L Kraft; Kevin Carnes; Kelly R Anderson; Jeanette Hayes-Klug; Edward A Hoover
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

Review 3.  Non-human primates in prion diseases.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Cell Tissue Res       Date:  2022-06-04       Impact factor: 5.249

Review 4.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

5.  Naturally prion resistant mammals: a utopia?

Authors:  Natalia Fernández-Borges; Francesca Chianini; Hasier Eraña; Enric Vidal; Samantha L Eaton; Belén Pintado; Jeanie Finlayson; Mark P Dagleish; Joaquín Castilla
Journal:  Prion       Date:  2012-09-06       Impact factor: 3.931

6.  Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies.

Authors:  Jan Priem; Jan P M Langeveld; Lucien J M van Keulen; Fred G van Zijderveld; Olivier Andreoletti; Alex Bossers
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

7.  Bovine PrP expression levels in transgenic mice influence transmission characteristics of atypical bovine spongiform encephalopathy.

Authors:  Rona Wilson; Patricia Hart; Pedro Piccardo; Nora Hunter; Cristina Casalone; Thierry Baron; Rona M Barron
Journal:  J Gen Virol       Date:  2012-02-01       Impact factor: 3.891

8.  Genetic predictions of prion disease susceptibility in carnivore species based on variability of the prion gene coding region.

Authors:  Paula Stewart; Lauren Campbell; Susan Skogtvedt; Karen A Griffin; Jon M Arnemo; Morten Tryland; Simon Girling; Michael W Miller; Michael A Tranulis; Wilfred Goldmann
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

9.  Genotype-dependent molecular evolution of sheep bovine spongiform encephalopathy (BSE) prions in vitro affects their zoonotic potential.

Authors:  Zuzana Krejciova; Marcelo A Barria; Michael Jones; James W Ironside; Martin Jeffrey; Lorenzo González; Mark W Head
Journal:  J Biol Chem       Date:  2014-08-06       Impact factor: 5.157

10.  Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.

Authors:  Pedro Piccardo; Declan King; Glenn Telling; Jean C Manson; Rona M Barron
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.